Concepedia

Author

Alexandre Bonet

Instituto de Química Orgánica GeneralORCID

Also Known As

A Bonet, A. Bonet, Alexandre Bonet

16

Publications

456

Citations

13

H-Index

34

Concepts

All Affiliations

Instituto de Química Orgánica GeneralLaboratoire de Chimie OrganiqueUniversidad de AlcaláUniversity of SfaxUniversity Hospital Hradec Králové
AB

About

Alexandre Bonet is an author at Instituto de Química Orgánica General specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

357

2

Biochemistry

7

7

290

3

Health Sciences

3

3

160

4

Natural Sciences

3

3

96

5

Allergy

1

1

47

Alexandre Bonet

×

14

Publications

453

Citations

13

H-Index

YearCitations

Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures

Dumrongsak Pekthong, Nadège Blanchard, Catherine Abadie,

Chemico-Biological Interactions

2008

75

Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide

Dumrongsak Pekthong, Hélène Martin, Catherine Abadie,

Journal of Ethnopharmacology

2007

68

Effects of long-term dietary intake of magnesium on oxidative stress, apoptosis and ageing in rat liver.

Hélène Martin, B. Uring‐Lambert, Markus Adrian,

PubMed

2008

47

Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy

Youssef Dgachi, Olga Sokolov, Vincent Luzet,

European Journal of Medicinal Chemistry

2016

40

Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of l-NAME

Delphine Binda, Dominique Lasserre-Bigot, Alexandre Bonet,

Toxicology in Vitro

2003

38

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease

Youssef Dgachi, Óscar M. Bautista‐Aguilera, Mohamed Benchekroun,

Molecules

2016

31

New (Benz)Imidazolopyridino Tacrines as Nonhepatotoxic, Cholinesterase Inhibitors for Alzheimer Disease

Houssem Boulebd, Lhassane Ismaïli, Hélène Martin,

Future Medicinal Chemistry

2017

28

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy

Houssem Boulebd, Lhassane Ismaïli, Manuela Bartolini,

Molecules

2016

25

Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro

Lysiane Richert, Gregor Tuschl, Catherine Viollon‐Abadie,

Drug Metabolism and Disposition

2008

24

Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers – A European Centre for Validation of Alternative Methods (ECVAM) – Funded pre-validation study

Lysiane Richert, Catherine Abadie, Alexandre Bonet,

Toxicology in Vitro

2009

20

Page 1